首页> 外文期刊>JPEN. Journal of parenteral and enteral nutrition. >Efficacy of Glutamine-Enriched Nutrition Support for Patients With Severe Acute Pancreatitis: A Meta-Analysis
【24h】

Efficacy of Glutamine-Enriched Nutrition Support for Patients With Severe Acute Pancreatitis: A Meta-Analysis

机译:谷氨酰胺丰富的营养支持对重症急性胰腺炎患者的疗效:一项荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Plasma glutamine (Gln) level has been negatively correlated with the severity of severe acute pancreatitis (SAP). Although Gln is widely used today, the results of individual randomized controlled trials of Gln-enriched nutrition support for patients with SAP are conflicting. Methods: PubMed, EMBASE, HighWire, Cochrane Central Register of Controlled Trials, Wanfang, China Journals Full-Text Database, and the Chinese Biomedical Literature Database were searched. Literature published before June 2014 was searched. Randomized controlled trials investigating the comparison of conventional and Gln-enriched nutrition support were included; a random effect model using Rev Man 5.2 software was chosen to complete this meta-analysis. The count data were analyzed using the risk ratio (RR) and 95% confidence interval (CI), and the measurement data were analyzed using the standard mean difference or weighted mean difference and 95% CI. Heterogeneity analyses were conducted by I-2 test; publication bias analyses were conducted by Begg test. Results: Ten studies were eventually chosen for analysis, including 218 patients who received conventional methods (control group) and 215 patients who received Gln-enriched nutrition support (experimental group). Compared with the control group, Gln is helpful in elevating the albumin level, decreasing C-reaction protein (standard mean difference = 1.01, -1.89; 95% CI: 0.50 to 1.51, -3.23 to -0.56; P < .05), decreasing the incidence of infectious complication and mortality (RR = 0.62, 0.36; 95% CI: 0.46 to 0.83, 0.16 to 0.83; P < .05), and shortening the hospital stay length (weighted mean difference [WMD] = -3.89; 95% CI: -4.98 to -2.81; P < .05) without increasing expenses (WMD = -0.16; 95% CI: -1.34 to 1.02; P > .05). Intravenous infusion manifested more advantages by decreasing the incidence of infectious complications and mortality. Conclusions: Gln-enriched nutrition support is superior to conventional methods for SAP, and intravenous infusion may be a better choice for drug administration.
机译:背景:血浆谷氨酰胺(Gln)水平与严重急性胰腺炎(SAP)的严重程度呈负相关。尽管如今已广泛使用Gln,但针对SAP患者的富含Gln的营养支持的个别随机对照试验的结果相互矛盾。方法:检索PubMed,EMBASE,HighWire,Cochrane对照试验中央注册系统,万方,《中国期刊全文数据库》和《中国生物医学文献数据库》。检索了2014年6月之前发表的文献。随机对照试验研究了传统营养和富含Gln的营养支持的比较。选择使用Rev Man 5.2软件的随机效应模型来完成该荟萃分析。使用风险比(RR)和95%置信区间(CI)分析计数数据,并使用标准平均差或加权平均差和95%CI分析测量数据。异质性分析通过I-2检验进行;通过Begg检验进行出版物偏倚分析。结果:最终选择了10项研究进行分析,包括218例接受常规方法的患者(对照组)和215例接受了Gln富营养支持的患者(实验组)。与对照组相比,Gln有助于提高白蛋白水平,降低C反应蛋白(标准平均差异= 1.01,-1.89; 95%CI:0.50至1.51,-3.23至-0.56; P <.05),降低感染并发症和死亡率的发生率(RR = 0.62,0.36; 95%CI:0.46至0.83,0.16至0.83; P <.05),并缩短住院时间(加权平均差[WMD] = -3.89; 95%CI:-4.98至-2.81; P <.05)而没有增加费用(WMD = -0.16; 95%CI:-1.34至1.02; P> .05)。静脉输液通过降低感染并发症的发生率和死亡率显示出更多的优势。结论:富含Gln的营养支持优于传统的SAP方法,静脉输注可能是给药的更好选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号